Hiscox has increased its capacity for US domiciled terrorism risk to $200mn as it responds to increased demand for the product with the upcoming expiration of the government backstop under TRIPRA.
Hiscox has increased its capacity for US domiciled terrorism risk to $200mn as it responds to increased demand for the product with the upcoming expiration of the government backstop under TRIPRA.